Trade CINGW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Cingulate Inc. Warrants (CINGW) is trading at US$0.01, down 1.41% today as of Aug 28, 12:19 EDT. Over the past 52 weeks, CINGW has traded between US$0.00 and US$0.12. On Syfe you can trade CINGW with $0 commission and add it to your watchlist.
| Previous close | US$0.01 |
|---|---|
| 52-week range | US$0.00 – US$0.12 |
| Volume | 50.7K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cingulate Inc. Warrants
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.
Year: 2021
Cingulate Inc. Warrants (CINGW) stock is trading at US$0.01, -1.41% from the previous close of US$0.01.
The 52-week high for Cingulate Inc. Warrants (CINGW) stock is US$0.12.
The 52-week low for Cingulate Inc. Warrants (CINGW) stock is US$0.00.
Cingulate Inc. Warrants (CINGW) does not currently pay a dividend.
Stay on top of CINGW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
